NCT04710147

Brief Summary

Due to acquired brain injury (ABI), is often difficulty in gait and balance alterations, as problems that patients designated as the most disabling. It is essential to an effective assessment of the balance. Objective: The purpose of the present project adapt and verify the validity of the scale Community Balance and Mobility (CB\&M), in patients with ABI in subacute and chronic stage, since that is postulated as a brief tool and covering the peculiarities of the specific alterations of the patient after suffering brain injury. Methodology: Between February 2021 and June 2022 will be transcultural adaptation to the ABI population and validation of psychometric scale CB\&M in three phases. 100 subjects who receive treatment in centers of attention to brain injury in Spain will be recruited. Results: validity and reliability parameters shall be calculated by means of descriptive statistics for each item of the scales and the set of scale score. Investigators will also analyze the internal consistency using Cronbach's alpha, the interclass correlation coefficient will be used to determine the reliability, and the items will be scanned with the Pearson coefficient: \> 0.20, among other parameters.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 12, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 14, 2021

Completed
26 days until next milestone

Study Start

First participant enrolled

February 9, 2021

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2022

Completed
Last Updated

November 4, 2022

Status Verified

November 1, 2022

Enrollment Period

1.3 years

First QC Date

January 12, 2021

Last Update Submit

November 3, 2022

Conditions

Keywords

Acquired Brain InjuryBalance AssessmentCentral Nervous System Diseases

Outcome Measures

Primary Outcomes (3)

  • 1. Test-retest Reliability

    the overall consistency measures the homogeneity of the scale and the interdependence of the items, indicating the relationship between them. To determine test-retest test reliability, the intraclass correlation coefficient (ICC) will be used. Derived from the test-retest reliability study, the measurement error will be calculated, using the formula standard deviation (SD) x √1-ICC.

    2 months

  • Validity

    To analyze the convergent validity, it will be applied on the first day of the week and before receiving treatment.

    2 months

  • Berg Balance Scale

    It evaluates deficiencies in balance in response to 14 points ranging from 0-worst balance to 4-best balance (total 56 points). Berg Balance Scale is the gold standard of comparison for obtaining validity

    2 months

Secondary Outcomes (1)

  • Sensitivity to change

    2 months

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Spanish population with Acquired Brain Injury.

You may qualify if:

  • The participants will be users from centers of attention to brain injury.
  • Adults who had suffered a ABI, at least 2 months before.
  • The disability before suffering ABI was less than or equal to three on the scale modified Rankin.
  • Lack of cognitive impairment scale Minimental State Examination, with a score is \> 24.
  • No previous diseases that alter the balance.
  • Clinically stable and without fever-
  • Ability to walk with technical support or without it.
  • Signing an informed consent.

You may not qualify if:

  • Medical contraindications to perform physical tests (acute or peripheral nervous system musculoskeletal disorders).
  • Not understand the instructions.
  • Subjects with severe aphasia.
  • Subjects with acute processes of any added pathology.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cristina Lirio-Romero

Toledo, 45001, Spain

Location

Related Publications (4)

  • Perennou D, Decavel P, Manckoundia P, Penven Y, Mourey F, Launay F, Pfitzenmeyer P, Casillas JM. [Evaluation of balance in neurologic and geriatric disorders]. Ann Readapt Med Phys. 2005 Jul;48(6):317-35. doi: 10.1016/j.annrmp.2005.04.009. French.

    PMID: 15932776BACKGROUND
  • Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, Erikson P; ISPOR Task Force for Translation and Cultural Adaptation. Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health. 2005 Mar-Apr;8(2):94-104. doi: 10.1111/j.1524-4733.2005.04054.x.

    PMID: 15804318BACKGROUND
  • Howe JA, Inness EL, Venturini A, Williams JI, Verrier MC. The Community Balance and Mobility Scale--a balance measure for individuals with traumatic brain injury. Clin Rehabil. 2006 Oct;20(10):885-95. doi: 10.1177/0269215506072183.

    PMID: 17008340BACKGROUND
  • Inness EL, Howe JA, Niechwiej-Szwedo E, Jaglal SB, McIlroy WE, Verrier MC. Measuring Balance and Mobility after Traumatic Brain Injury: Validation of the Community Balance and Mobility Scale (CB&M). Physiother Can. 2011 Spring;63(2):199-208. doi: 10.3138/ptc.2009-45. Epub 2011 Apr 13.

    PMID: 22379260BACKGROUND

MeSH Terms

Conditions

Brain Injury, ChronicBrain InjuriesCentral Nervous System Diseases

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsWounds and Injuries

Study Officials

  • Cristina Lirio-Romero, PhD

    University of Castilla-La Mancha

    PRINCIPAL INVESTIGATOR
  • Marta Fernández-Hontoria, BsC

    Centro de Referencia Estatal de Atención Al Daño Cerebral

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Target Duration
2 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 12, 2021

First Posted

January 14, 2021

Study Start

February 9, 2021

Primary Completion

June 15, 2022

Study Completion

August 30, 2022

Last Updated

November 4, 2022

Record last verified: 2022-11

Locations